ERBB2 and breast carcinoma: HER2-targeted therapies, trastuzumab (Herceptin®) and/or pertuzumab (Perjeta®) and/or chemotherapeutic agents, are effective therapeutic regimens in breast cancer with HER2 overexpression and/or amplification.